Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$5.9 - $6.95 $574,660 - $676,930
97,400 New
97,400 $641,000
Q4 2021

Feb 11, 2022

SELL
$15.69 - $21.14 $15 - $21
-1 Reduced -0.0%
28,194 $442,000
Q3 2021

Nov 10, 2021

SELL
$15.35 - $21.27 $214,071 - $296,631
-13,946 Reduced 33.09%
28,195 $484,000
Q2 2021

Aug 16, 2021

BUY
$15.71 - $21.51 $662,035 - $906,452
42,141 New
42,141 $907,000
Q2 2020

Aug 14, 2020

SELL
$9.66 - $12.02 $539,346 - $671,112
-55,833 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$7.5 - $16.8 $556,492 - $1.25 Million
-74,199 Reduced 57.06%
55,833 $578,000
Q4 2019

Feb 13, 2020

BUY
$12.38 - $17.47 $906,847 - $1.28 Million
73,251 Added 129.01%
130,032 $2.13 Million
Q3 2019

Nov 13, 2019

SELL
$12.27 - $15.79 $1.03 Million - $1.32 Million
-83,591 Reduced 59.55%
56,781 $754,000
Q2 2019

Aug 08, 2019

SELL
$13.37 - $18.85 $22,555 - $31,799
-1,687 Reduced 1.19%
140,372 $1.98 Million
Q1 2019

May 13, 2019

SELL
$17.59 - $31.05 $14,582 - $25,740
-829 Reduced 0.58%
142,059 $2.61 Million
Q4 2018

Feb 14, 2019

SELL
$18.97 - $31.47 $103,860 - $172,298
-5,475 Reduced 3.69%
142,888 $3.73 Million
Q3 2018

Nov 13, 2018

BUY
$18.25 - $23.0 $235,479 - $296,769
12,903 Added 9.53%
148,363 $3.41 Million
Q2 2018

Aug 13, 2018

SELL
$13.95 - $19.15 $10,574 - $14,515
-758 Reduced 0.56%
135,460 $2.58 Million
Q1 2018

May 14, 2018

BUY
$14.05 - $20.2 $54,837 - $78,840
3,903 Added 2.95%
136,218 $2.3 Million
Q4 2017

Feb 13, 2018

SELL
$12.85 - $18.1 $19,364 - $27,276
-1,507 Reduced 1.13%
132,315 $2.01 Million
Q3 2017

Nov 13, 2017

SELL
$15.4 - $18.85 $17,171 - $21,017
-1,115 Reduced 0.83%
133,822 $2.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,451 Added 4.21%
134,937 $2.2 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-10,594 Reduced 7.56%
129,486 $1.81 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-12,384 Reduced 8.12%
140,080 $2.23 Million
Q3 2016

Apr 17, 2019

BUY
N/A
152,464
152,464 $2.54 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.